Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh
At the beginning of the coronavirus disease 2019 (COVID-19) pandemic in Bangladesh, there was a scarcity of ideal biocontainment facilities to detect the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a risk group of 3 organisms. Molecular detection of SARS-CoV-2 must be performed in...
Saved in:
| Main Authors: | SM Rashed Ul Islam, Tahmina Akther, Sharmin Sultana, Paroma Deb, Asish Kumar Ghosh, Md. Abdullah Omar Nasif, Amirul Huda Bhuiyan, Munira Jahan, Afzalun Nessa, Saif Ullah Munshi, Shahina Tabassum |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2021-12-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/14415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VIRAL BIOSAFETY OF BIOPHARMACEUTICALS
by: D. A. Gusarov
Published: (2019-01-01) -
Biosafety perspective of clinical laboratory workers: a profile of Pakistan
by: Sadia Nasim, et al.
Published: (2012-08-01) -
Establishing a national biosafety and biosecurity agency for the United States
by: David R. Gillum, et al.
Published: (2024-10-01) -
Biosafety and Environmental Risks of Genetically Modified Plants.
by: Anmar Alalwani, et al.
Published: (2024-06-01) -
Biosafety and pharmacokinetic characteristics of polyethylene pyrrolidone modified nano selenium in rats
by: Wei Li, et al.
Published: (2024-11-01)